ATF5 knockdown inhibited tumor growth (Fig. 1C) and significantly increased median survival (Fig. 1D; 42 vs. 27 days, + Dox vs. −Dox, respectively, P  =  0.0083). Here, ATF5 is linked to neoplasm.